Related Experiment Video
Updated: May 10, 2026

Mouse Models Of Helicobacter Infection And Gastric Pathologies
Published on: October 18, 2018
cagE as a biomarker of the pathogenicity of Helicobacter pylori
Ivy Bastos Ramis1, Júlia Silveira Vianna, Lande Vieira da Silva Junior
1Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, RS, Brasil.
Introduction:
Helicobacter pylori infection is associated with gastro-duodenal diseases. Genes related to pathogenicity have been described for H. pylori and some of them appear to be associated with more severe clinical outcomes of the infection. The present study investigates the role of cagE as a pathogenicity biomarker of H. pylori compare it to cagA, vacA, iceA and babA2 genes and correlate with endoscopic diagnoses.
Methods:
Were collected biopsy samples of 144 dyspeptic patients at the Hospital of the Federal University of Rio Grande, Rio Grande do Sul, Brazil. After collection, the samples were sent for histological examination, DNA extraction and detection of all putative pathogenicity genes by PCR.
Results:
Of the 144 patients undergoing endoscopy, 57 (39.6%) presented H. pylori by histological examination and PCR by detection of the ureA gene. Based on the endoscopic diagnoses, 45.6% (26/57) of the patients had erosive gastritis, while 54.4% (31/57) had enanthematous gastritis. The genes cagA, cagE, vacAs1/m1, vacAs1/m2 and iceA1 were related to erosive gastritis, while the genes vacAs2/m2, iceA2 and babA2 were associated to enanthematous gastritis. We found a statistically significant association between the presence of cagE and the endoscopic diagnosis. However, we detect no statistically significant association between the endoscopic diagnosis and the presence of cagA, vacA, iceA and babA2, although a biological association has been suggested. Conclusions Thus, cagE could be a risk biomarker for gastric lesions and may contribute to a better evaluation of the H. pylori pathogenic potential and to the prognosis of infection evolution in the gastric mucosa.
Insights
The cagE gene in Helicobacter pylori is a significant biomarker for gastric lesions, potentially aiding in evaluating infection severity and prognosis. Other genes like cagA showed no significant association in this study.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Molecular Biology
Background:
- Helicobacter pylori infection is linked to gastro-duodenal diseases.
- Pathogenicity genes in H. pylori may correlate with severe clinical outcomes.
- The study focuses on the cagE gene's role as a biomarker.
Purpose of the Study:
- Investigate cagE as a pathogenicity biomarker for H. pylori.
- Compare cagE to other H. pylori genes (cagA, vacA, iceA, babA2).
- Correlate gene presence with endoscopic diagnoses.
Main Methods:
- Collected biopsy samples from 144 dyspeptic patients.
- Performed histological examination and DNA extraction.
- Detected pathogenicity genes using Polymerase Chain Reaction (PCR).
Main Results:
- H. pylori detected in 39.6% of patients (57/144).
- Significant association found between cagE presence and endoscopic diagnosis (erosive vs. enanthematous gastritis).
- No significant association detected for cagA, vacA, iceA, and babA2 with endoscopic findings.
Conclusions:
- cagE may serve as a risk biomarker for gastric lesions.
- cagE can improve evaluation of H. pylori pathogenic potential.
- cagE aids in predicting H. pylori infection prognosis in gastric mucosa.
More Related Videos
05:13Rapid Detection of Helicobacter pylori Virulence and Typing Using Quantum Dot Labeling Technology
Published on: June 13, 2025
09:05High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
Published on: November 21, 2014
Related Concept Videos
Gastritis II: Pathophysiology
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy